A bullish thesis on Markel Group Inc. highlights the insurer and investment holding company as a long-term compounder with disciplined underwriting and capital allocation. The combined ratio improved to 92.8% from 96.0%, driving higher operating profit, while international insurance grew and U.S. specialty lines reduced lower-quality risks. Markel Ventures showed mixed but resilient performance, and investment income remains a stable recurring engine at roughly $1 billion annually. Management is prioritizing share repurchases, and intrinsic value is estimated around $2,600 per share, suggesting the stock is meaningfully undervalued.
Markel CorporationArticle highlights improved combined ratio, higher operating profit, and share repurchases, with intrinsic value estimated at $2,600 per share, indicating undervaluation.